This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: D&p Biotech Ltd., Yonsei University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: Innovations by Doo Hyun Park in Medical Imaging
Introduction
Doo Hyun Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical imaging, particularly in the prognosis of cancer patients. His innovative approach utilizes image features to enhance the accuracy of prognosis predictions for patients suffering from adenocarcinoma.
Latest Patents
Doo Hyun Park holds a patent for a method of predicting the prognosis of a patient with adenocarcinoma using image features. The patent describes a comprehensive process that includes receiving an image containing a lesion region, preprocessing the image, segmenting the lesion region, and calculating biomarkers that indicate intensity and texture information. This method ultimately outputs a prognosis prediction value based on the calculated biomarkers, showcasing a significant advancement in medical diagnostics.
Career Highlights
Throughout his career, Doo Hyun Park has worked with reputable organizations such as D&P Biotech Ltd. and Yonsei University. His experience in these institutions has allowed him to collaborate with other experts in the field and further develop his innovative methods.
Collaborations
Doo Hyun Park has collaborated with notable colleagues, including Do Sik Hwang and Myung Hoon Lee. These partnerships have contributed to the advancement of his research and the successful implementation of his patented methods.
Conclusion
Doo Hyun Park's contributions to medical imaging and cancer prognosis prediction represent a significant step forward in the field. His innovative methods and collaborations with esteemed colleagues highlight his dedication to improving patient outcomes through technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile